36C77026Q0061 Request for Information (RFI): Domestic Pharmaceutical Manufacturing 36C77026Q0061 1. Overview The Department of Veterans Affairs (VA), Consolidated Mail Outpatient Pharmacy (CMOP) operates seven sites across the United States, supporting the daily mailout of approximately 450,000 prescriptions to Veterans. While the majority of these prescriptions are fulfilled through the Prime Vendor contract, CMOP supplements its supply through Open Market (OM) purchases when necessary, through solicitations that get published to the System for Award Management (SAM) website, similar to how this RFI is being published. To support these OM requirements, the Government has an ongoing need to identify pharmaceutical end items manufactured, processed, or produced by domestic small and large businesses. This RFI is issued solely for market research and procurement planning purposes and does not constitute a Request for Quote (RFQ) or Request for Proposal (RFP). This notice shall not be construed as a commitment by the Government to ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. This request does not constitute a solicitation for proposals or quotes or the authority to enter into negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort. Related details can be found in section six (6) regarding the nature of this RFI. 2. Purpose The purpose of this RFI is to: Identify domestic small and large business pharmaceutical manufacturers with efficient production capabilities related to FAR Part 12 Acquisition of Commercial Products and Commercials Services in combination with FAR Part 25 Foreign Acquisition procedures. Gather information on manufacturers of pharmaceuticals and ancillary items related to CMOP s OM purchases. Promote early exchanges of information in accordance with Federal Acquisition Regulation (FAR) Overhaul Part 15.101, to improve mutual understanding of Government needs and industry capabilities. Deeper Insight into Small Business type considerations in manufacturing to include all socio-economic considerations with the highest interest in Service-Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Business (VOSB) Manufacturers. 3. Scope The overall intent of the RFI is to provide outreach within the designated NAICS codes: 325412 - Pharmaceutical Preparation Manufacturing 325413 - In-Vitro Diagnostic Substance Manufacturing The list presented below is not exhaustive of pharmaceutical and medical surgical items that may be required in Fiscal Year (FY) 26 and is subject to be updated periodically as our requirements change. CMOP is seeking information from both small and large domestic manufacturers capable of providing the following items to support CMOP s OM needs: Station item # Pharmaceutical Description Treatment 16822 ABALOPARATIDE 80MCG/O.04ML PEN 156ML Used for those who suffer from high risk osteoporosis 10834 ACAMPROSATE CA 333MG TAB Used to help overcome alcoholism 18491 ARMODAFINIL 250MGTAB Used to treat excessive sleepiness (narcolepsy) 12784 ARMODAFINIL 50MG TAB Used to treat excessive sleepiness (narcolepsy) 2955 ARTIFICIAL SALIVA ORAL SPRAY Used to treat dry mouth or bad breath 13125 BREAST MILK, STORAGE BAGS, 100ct Used to store breast milk 15663 BRIMONIDINE TARTRATE 0.025% OPH SOLN Used to lower pressure inside the eye 12679 CALCIUM 500MG/VITAMIN D 500UNIT CHEW TAB Used to treat low calcium and vitamin D levels 13707 CARBOXYMETHYLCELLULOSE NA 0.25% OPH SOLN 15ML Used to treat dry eyes XV066 CATH SET, INTERMIT 14FR H#96144 Used to drain the bladder XT265 CATH,EXTERNAL EXTENDED WEAR MED H#9207 Used to drain the bladder C0820 CLINDAMYCIN P04 1% TOP SWAB Used to treat acne lesions C0482 CLOMIPHENE CITRATE 50MG TAB Used to induce ovulation (egg production) C0731 COAL TAR 2% SHAMPOO Used to treat eczema, psoriasis, dermatitis, and other skin disorders C0609 COLESTIPOL HCL 1GM TAB Used to lower high cholesterol levels in the blood D0025 DESONIDE 0.05% CREAM,TOP Used to relieve redness, itching and other discomfort caused by skin conditions D0938 DORZOLAMIDE 22.3/TIMOLOL6.8MG/ML PF OPH used to treat increased pressure in the eye D0828 DORZOLAMIDE 22.3_TIMOLOL6.8MG_ML OPH SOL Used to treat increased pressure in the eye XH825 DRESSING,DRAWTEX 4IN X 4IN Treatment in wound care D1217 DROSPIRENONE 4MG TAB,28 Used to prevent ovulation and pregnancy D0922 DULOXETINE HCL 20MG EC CAP Used to treat depression and anxiety D0929 DULOXETINE HCL 30MG EC CAP Used to treat depression and anxiety D0924 DULOXETINE HCL 60MG EC CAP Used to treat depression and anxiety XJ196 ELECTRODE PAD EARCLIP AS#EEP Used with an electrotherapy stimulator for the treat anxiety, depression, and insomnia E0811 ESOMEPRAZOLE 20MG (BASE) EC CAP Used for the treatment of erosive esophagitis E0301 EYELID CLEANSER,EYE SCRUB PAD Used to maintain ocular surface health for patients with blepharitis, MGD, and demodex infections XK812 FEMALE CONDOM,INTERNAL Used to help prevent pregnancy and reduce the risk of sexually transmitted diseases F0355 FENOFIBRATE 145MG TAB Used to reduce elevated low-density lipoprotein cholesterol F0354 FENOFIBRATE 48MG TAB Used to reduce elevated low-density lipoprotein cholesterol F0423 FESOTERODINE FUMARATE 4MG SA TAB Used for the treatment of overactive bladder F0135 FOSINOPRIL NA 40MG TAB 90CT Used for the treatment of hypertension G0257 GALANTAMINE HYDROBROMIDE 8MG SA CAP Treatment of mild to moderate dementia of the Alzheimer's G0194 GLIPIZIDE 2.5MG SA TAB Used to improve glycemic control in adults with diabetes H0066 HYDROCORTISONE ACETATE 25MG RTL SUPP Used to treat hemorrhoids I0004 IBUPROFEN 400MG TAB Used to treat pain, fever, and inflammation I0005 IBUPROFEN 600MG TAB Used to treat pain, fever, and inflammation I0006 IBUPROFEN 800MG TAB Used to treat pain, fever, and inflammation J0040 JASMIEL TAB,28 Used to prevent pregnancy L0329 LANSOPRAZOLE 15MG SA DISINTEGRATING TAB Treatment of ulcers L0330 LANSOPRAZOLE 30MG SA DISINTEGRATING TAB Treatment of ulcers XZ156 LEG BAG COMBINATION PK H#9349 LATEX FREE Used to collect urine through a catheter drain tube L0780 LEVODOPA 42MG INHL CAP Used in the treatment of Parkinson disease as a dopamine replacement LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB used to treat different types of bacterial infections. M1295 METFORMIN (EQV-FORTAMET) 1000MG SA TAB Management of type 2 diabetes M0103 MINOCYCLINE HCL 50MG CAP Used to treat infections cased by bacteria N0567 NEBIVOLOL 5MG TAB Used to treat high blood pressure XZ173 ONE TOUCH ULTRA (GLUCOSE) TEST STRIPS 50CT & 100CT Used to test blood glucose levels in managing type 1 & 2 diabetes XH026 PAD,NURSING DISPOSABLE Used on breast feeding mothers to absorb any milk that may leak between feedings P0535 PIOGLITAZONE HCL 15MG TAB Management of type 2 diabetes P0536 PIOGLITAZONE HCL 30MG TAB Management of type 2 diabetes P0537 PIOGLITAZONE HCL 45MG TAB Management of type 2 diabetes P0110 PREDNISONE 1MG TAB 1000CT Corticosteriod used on the immune system to help relieve swelling, redness, itching, and allergic reactions P0156 PROPRANOLOL HCL 60MG SA CAP - 33030 used to treat high blood pressure P0175 PYRIDOSTIGMINE BROMIDE 60MG TAB Used to treat myasthenia gravis muscle weakness R0233 RESOURCE BENEPROTEIN PWDR,227GM used to supply protein needed to help maintain muscle. For patients that can t eat food. XJ330 SET,INFUSION AUTOSOFT XC TANDEM #1001680 Used to manage diabetes by delivering insulin from a pump to the body XJ441 SET,INFUSION AUTOSOFT XC TANDEM #1001729 Used to manage diabetes by delivering insulin from a pump to the body S0578 SEVELAMER CARBONATE 800MG TAB For the control of serum phosphorus in adults with chronic kidney disease on dialysis S0167 SODIUM CHLORIDE 2% OPH SOLN Used to reduce surface corneal swelling of the eye S0174 SUMATRIPTAN 6MG_0.5ML INJ SYRINGE 0.5ML Used for treatment of migraines U0004 UREA 40% CREAM Used to treat dry/rough skin conditions and some nail problems Z0005 ZINC OXIDE 20% OINT (60GM & 464GM) Used to treat or prevet skin irritation Z0067 ZOLPIDEM TARTRATE 12.5MG SA TAB Used to treat insomnia 4. Submission Guidelines If your company manufactures pharmaceuticals that are not listed above and are produced domestically in accordance with (IAW) FAR Part 25.001(c), please provide the following information: Company Information: Name, physical address, and point of contact Physical address of domestic manufacturing facility Socioeconomic status (e.g., SDVOSB, VOSB, 8(a), etc.) to include both large and small business types Business size and SAM UEI Number Product Information: List of domestically manufactured pharmaceuticals FDA-approved NDC numbers Treatment usage of each pharmaceutical Authorized distributors Average cost for common prescription quantities Operational Capability: Manufacturing facility production capacity (volume) Frequency of stockouts in the past 12 months Typical replenishment timelines Commercial entities where the items have been sold to for ultimate large volume dispensing. Contracting Information: GSA/FSS/NAC contract numbers (if applicable) Suggested alternative NAICS or PSC codes, if more appropriate Compliance: Any manufacturer responding to this announcement must be able to show their capability to comply with: Ability to meet federal, state, and local regulations Capacity to support all seven CMOP sites if needed Interested manufacturers are reminded that in accordance with FAR 4.12, prospective contractors shall complete electronic annual representations and certifications in conjunction with FAR 4.11 required registration in the System for Award Management (SAM) database prior to award of a contract. 5. Response Instructions: If you believe you are capable of meeting the requirement, please provide a complete capability statement and response by March 15, 2026, at 4:30 pm CT to: Michael McAlhaney Email:
[email protected] Tresanna Tacia Email:
[email protected] Subject Line of Email: Must start with the 1) RFI Number 36C77026Q0061 followed by the 2) generic pharmaceutical name. The proprietary name should only be used when there are no FDA approved generic options. Use the Excel Spreadsheet inputs as identified as Manufacturer Inputs_Excel as part of a complete submission. 6. Important Notice PLEASE NOTE: This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Respondents are solely responsible for all expenses associated with responding to this RFI. The Government does not intend to award a contract on the basis of the RFI or otherwise pay for the information requested. Responses will be treated as information only and not as a proposal.